Springer (part of Springer Nature), Osteoporosis International, 3(22), p. 943-954
DOI: 10.1007/s00198-010-1309-z
Full text: Download
We examined new users of osteoporosis drugs among seniors in Pennsylvania and found no evidence of healthy adherer bias on observed associations between adherence to treatment and non-vertebral fracture risk; we document fracture reduction with better adherence to bisphosphonates, yet no fracture reduction with better adherence to calcitonin or raloxifene.